Development and validation of a prealbumin–bilirubin model for prognostic prediction in intermediate hepatocellular carcinoma undergoing transarterial chemoembolization

Development and validation of a prealbumin–bilirubin model for prognostic prediction in intermediate hepatocellular carcinoma undergoing transarterial chemoembolization

Abstract To establish and validate a novel prognostic model to predict outcomes for intermediate hepatocellular carcinoma (HCC) patients undergoing transarterial chemoembolization (TACE). Clinical data from intermediate-stage HCC patients who underwent TACE between January 2007 and December 2020 wer...

Full description

Saved in:
Bibliographic Details
Main Authors: Nan Jiang, Yi Zhan, Shuai Zhang, Binyan Zhong, Jun Yang, Yu Yin, Wanci Li, Mingming Li, Jian Shen, Zhi Li, Xiaoli Zhu, Caifang Ni
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Prealbumin
Hepatocellular carcinoma
Transarterial chemoembolization
Prognostic model
Online Access:https://doi.org/10.1038/s41598-025-02960-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-02960-6

Similar Items